메뉴 건너뛰기




Volumn 13, Issue 9, 2007, Pages 588-602

Peptides as tools and drugs for immunotherapies

Author keywords

Epitope mapping; Glycopeptide mapping; Mass spectrometry; Monoclonal antibodies; Peptide mapping; Subunit vaccines

Indexed keywords

ANTIBODY CONJUGATE; B LYMPHOCYTE ANTIGEN; BEVACIZUMAB; CETUXIMAB; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ESCHERICHIA COLI PROTEIN; ESCHERICHIA COLI VACCINE; HLA A2 ANTIGEN; IMMUNOGLOBULIN G; KEYHOLE LIMPET HEMOCYANIN MONOCLONAL ANTIBODY CONJUGATE; MELANOMA VACCINE; OUTER MEMBRANE PROTEIN A; PALIVIZUMAB; PEPTIDE; PEPTIDE DERIVATIVE; PEPTIDE ELA; PROTEIN P40; PYROGLUTAMIC ACID DERIVATIVE; RECOMBINANT PROTEIN BBG2NA; RECOMBINANT VACCINE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; SOMATOMEDIN C RECEPTOR; T LYMPHOCYTE ANTIGEN; TRASTUZUMAB; TUMOR VACCINE; UNCLASSIFIED DRUG; VACCINE; VIRUS VACCINE;

EID: 34848837625     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.852     Document Type: Review
Times cited : (21)

References (72)
  • 1
    • 0036721765 scopus 로고    scopus 로고
    • Multipin peptide libraries for antibody and receptor epitope screening and characterization
    • Tribbick G. Multipin peptide libraries for antibody and receptor epitope screening and characterization. J. Immunol. Methods 2002; 267(1): 27-35.
    • (2002) J. Immunol. Methods , vol.267 , Issue.1 , pp. 27-35
    • Tribbick, G.1
  • 2
    • 0036721834 scopus 로고    scopus 로고
    • The SPOT synthesis technique-synthetic peptide arrays on membrane supports-principles and applications
    • Frank R. The SPOT synthesis technique-synthetic peptide arrays on membrane supports-principles and applications. J. Immunol. Methods 2002; 267(1): 13-26.
    • (2002) J. Immunol. Methods , vol.267 , Issue.1 , pp. 13-26
    • Frank, R.1
  • 3
    • 14844314775 scopus 로고    scopus 로고
    • Cancer vaccines and immunotherapies: Emerging perspectives
    • Henderson RA, Mossman S, Nairm N, Cheever MA. Cancer vaccines and immunotherapies: emerging perspectives. Vaccine 2005; 23(17-18): 2359-2362,
    • (2005) Vaccine , vol.23 , Issue.17-18 , pp. 2359-2362
    • Henderson, R.A.1    Mossman, S.2    Nairm, N.3    Cheever, M.A.4
  • 5
    • 0034670017 scopus 로고    scopus 로고
    • Priming by microbial antigens from the intestinal flora determines the ability of CD4+ T cells to rapidly secrete IL-4 in BALB/c mice infected with Leshmania major
    • Julia V, McSorley SS, Malherbe L, Breittmayer JP, Girard-Pipau F, Beck A, Glaichenhaus N. Priming by microbial antigens from the intestinal flora determines the ability of CD4+ T cells to rapidly secrete IL-4 in BALB/c mice infected with Leshmania major. J. Immunol. 2000; 165: 5637-5645.
    • (2000) J. Immunol , vol.165 , pp. 5637-5645
    • Julia, V.1    McSorley, S.S.2    Malherbe, L.3    Breittmayer, J.P.4    Girard-Pipau, F.5    Beck, A.6    Glaichenhaus, N.7
  • 8
    • 20444363121 scopus 로고    scopus 로고
    • Ultra-potent antibodies against respiratory syncytial virus: Effects of binding kinetics and binding valence on viral neutralization
    • Wu H, Pfarr DS, Tang Y, An LL, Patel NK, Watkins JD, Huse WD, Kiener PA, Young JF. Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization. J. Mol. Biol. 2005; 350(1): 126-144.
    • (2005) J. Mol. Biol , vol.350 , Issue.1 , pp. 126-144
    • Wu, H.1    Pfarr, D.S.2    Tang, Y.3    An, L.L.4    Patel, N.K.5    Watkins, J.D.6    Huse, W.D.7    Kiener, P.A.8    Young, J.F.9
  • 10
    • 0030744003 scopus 로고    scopus 로고
    • Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide
    • Corvaia N, Tournier P, Nguyen TN, Haeuw JF, Power UF, Binz H, Andreoni C. Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide. J. Infect. Dis. 1997; 176(3): 560-569.
    • (1997) J. Infect. Dis , vol.176 , Issue.3 , pp. 560-569
    • Corvaia, N.1    Tournier, P.2    Nguyen, T.N.3    Haeuw, J.F.4    Power, U.F.5    Binz, H.6    Andreoni, C.7
  • 11
    • 0033602701 scopus 로고    scopus 로고
    • Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment
    • Plotnicky-Gilquin H, Huss T, Aubry JP, Haeuw JF, Beck A, Bonnefoy JY, Nguyen TN, Power UF. Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment. Virology 1999; 258(1): 128-140.
    • (1999) Virology , vol.258 , Issue.1 , pp. 128-140
    • Plotnicky-Gilquin, H.1    Huss, T.2    Aubry, J.P.3    Haeuw, J.F.4    Beck, A.5    Bonnefoy, J.Y.6    Nguyen, T.N.7    Power, U.F.8
  • 12
    • 33646146936 scopus 로고    scopus 로고
    • Protection of mice against Human respiratory syncytial virus by wild-type and aglycosyl mouse-human chimaeric IgG antibodies to subgroup-conserved epitopes on the G glycoprotein
    • Mekseepralard C, Toms GL, Routledge EG. Protection of mice against Human respiratory syncytial virus by wild-type and aglycosyl mouse-human chimaeric IgG antibodies to subgroup-conserved epitopes on the G glycoprotein. J. Gen. Virol. 2006; 87(Pt 5): 1267-1273.
    • (2006) J. Gen. Virol , vol.87 , Issue.PART 5 , pp. 1267-1273
    • Mekseepralard, C.1    Toms, G.L.2    Routledge, E.G.3
  • 13
    • 0034212718 scopus 로고    scopus 로고
    • Influence of live respiratory syncytial virus priming on the immune response generated by a recombinant vaccine candidate, BBG2Na
    • Goetsch L, Plotnicky-Gilquin H, Champion T, Beck A, Haeuw JF, Nguyen TN, Bonnefoy JY, Corvaïa N. Influence of live respiratory syncytial virus priming on the immune response generated by a recombinant vaccine candidate, BBG2Na. Vaccine 2000; 18: 2648-2655.
    • (2000) Vaccine , vol.18 , pp. 2648-2655
    • Goetsch, L.1    Plotnicky-Gilquin, H.2    Champion, T.3    Beck, A.4    Haeuw, J.F.5    Nguyen, T.N.6    Bonnefoy, J.Y.7    Corvaïa, N.8
  • 14
    • 0034212397 scopus 로고    scopus 로고
    • Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidate
    • Goetsch L, Plotnicky-Gilquin H, Champion T, Beck A, Corvaia N, Stahl S, Bonnefoy JY, Nguyen TN, Power UF. Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidate. Vaccine 2000; 18(24): 2735-2742.
    • (2000) Vaccine , vol.18 , Issue.24 , pp. 2735-2742
    • Goetsch, L.1    Plotnicky-Gilquin, H.2    Champion, T.3    Beck, A.4    Corvaia, N.5    Stahl, S.6    Bonnefoy, J.Y.7    Nguyen, T.N.8    Power, U.F.9
  • 15
    • 0034030608 scopus 로고    scopus 로고
    • CD4+ T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment
    • Plotnicky-Gilquin H, Robert A, Chevalet L, Haeuw JF, Beck A, Bonnefoy JY, brandt C, Siegrist CA, Nguyen TN, Power UF. CD4+ T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment. J. Virol. 2000; 74(8): 3455-3463.
    • (2000) J. Virol , vol.74 , Issue.8 , pp. 3455-3463
    • Plotnicky-Gilquin, H.1    Robert, A.2    Chevalet, L.3    Haeuw, J.F.4    Beck, A.5    Bonnefoy, J.Y.6    brandt, C.7    Siegrist, C.A.8    Nguyen, T.N.9    Power, U.F.10
  • 16
    • 0036786453 scopus 로고    scopus 로고
    • Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial vires G protein fragment
    • Plotnicky-Gilquin H, Cyblat-Chanal D, Aubry JP, Champion T, Beck A, Nguyen T, Bonnefoy JY, Corvaia N. Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial vires G protein fragment. J. Virol. 2002; 76(20): 10203-10210.
    • (2002) J. Virol , vol.76 , Issue.20 , pp. 10203-10210
    • Plotnicky-Gilquin, H.1    Cyblat-Chanal, D.2    Aubry, J.P.3    Champion, T.4    Beck, A.5    Nguyen, T.6    Bonnefoy, J.Y.7    Corvaia, N.8
  • 18
  • 20
    • 0037247022 scopus 로고    scopus 로고
    • Identification of B- and T-cell epitopes of BB, a carrier protein derived from the G protein of Streptococcus strain G148
    • Goetsch L, Haeuw JF, Champion T, Lacheny C, N'Guyen T, Beck A, Corvaia N. Identification of B- and T-cell epitopes of BB, a carrier protein derived from the G protein of Streptococcus strain G148. Clin. Diagn. Lab Immunol. 2003; 10(1): 125-132.
    • (2003) Clin. Diagn. Lab Immunol , vol.10 , Issue.1 , pp. 125-132
    • Goetsch, L.1    Haeuw, J.F.2    Champion, T.3    Lacheny, C.4    N'Guyen, T.5    Beck, A.6    Corvaia, N.7
  • 23
    • 19344366184 scopus 로고    scopus 로고
    • Proteomics for development of immunotherapies
    • Hondermack H ed, Kluwer Academic: The Netherlands
    • Haeuw JF, Beck A. Proteomics for development of immunotherapies. In Proteomics: Biomedical and Pharmaceutical Applications, Hondermack H (ed.). Kluwer Academic: The Netherlands, 2004; 243-278.
    • (2004) Proteomics: Biomedical and Pharmaceutical Applications , pp. 243-278
    • Haeuw, J.F.1    Beck, A.2
  • 24
    • 0034770788 scopus 로고    scopus 로고
    • Residual DNA quantification in clinical batches of BBG2Na, a recombinant subunit vaccine against human respiratory syncytial virus
    • Lokteff M, Klinguer-Hamour C, Julien E, Picot D, Lannes L, Nguyen TN, Bonnefoy JY, Beck A. Residual DNA quantification in clinical batches of BBG2Na, a recombinant subunit vaccine against human respiratory syncytial virus. Biologicals 2001; 29: 123-132.
    • (2001) Biologicals , vol.29 , pp. 123-132
    • Lokteff, M.1    Klinguer-Hamour, C.2    Julien, E.3    Picot, D.4    Lannes, L.5    Nguyen, T.N.6    Bonnefoy, J.Y.7    Beck, A.8
  • 25
    • 34848871541 scopus 로고    scopus 로고
    • Beck A. Testing tissues for residual DNA in vaccines. In World Health Organization informal consultation on the application of molecular methods to assure the quality, safety and efficacy of vaccines (Geneva April 7-8, 2005). Shin J, Wood D, Robertson J, Minor P, Peden K; on behalf of the WHO Informal Consulting Group. Biologicals 2007; 35: 63-71.
    • Beck A. Testing tissues for residual DNA in vaccines. In World Health Organization informal consultation on the application of molecular methods to assure the quality, safety and efficacy of vaccines (Geneva April 7-8, 2005). Shin J, Wood D, Robertson J, Minor P, Peden K; on behalf of the WHO Informal Consulting Group. Biologicals 2007; 35: 63-71.
  • 27
    • 0033971802 scopus 로고    scopus 로고
    • Synthesis and characterization of respiratory syncytial virus protein G related peptides containing two disulfide bridges
    • Beck A, Zorn N, Bussat MC, Haeuw JF, Corvaïa N, Nguyen TN, Bonnefoy JY, Van Dorsselaer A. Synthesis and characterization of respiratory syncytial virus protein G related peptides containing two disulfide bridges. J. Pept. Res. 2000; 55(1): 24-35.
    • (2000) J. Pept. Res , vol.55 , Issue.1 , pp. 24-35
    • Beck, A.1    Zorn, N.2    Bussat, M.C.3    Haeuw, J.F.4    Corvaïa, N.5    Nguyen, T.N.6    Bonnefoy, J.Y.7    Van Dorsselaer, A.8
  • 28
    • 0032991559 scopus 로고    scopus 로고
    • Identification of Multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein
    • Plotnicky-Gilquin H, Goetsch L, Huss T, Champion T, Beck A, Haeuw JF, Nguyen TN, Bonnefoy JY, Corvaïa N, Power UF. Identification of Multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein. J. Virol. 1999; 73(7): 5637-5645.
    • (1999) J. Virol , vol.73 , Issue.7 , pp. 5637-5645
    • Plotnicky-Gilquin, H.1    Goetsch, L.2    Huss, T.3    Champion, T.4    Beck, A.5    Haeuw, J.F.6    Nguyen, T.N.7    Bonnefoy, J.Y.8    Corvaïa, N.9    Power, U.F.10
  • 31
  • 32
    • 0029889228 scopus 로고    scopus 로고
    • Proposed three-dimensional model for the attachment protein G of respiratory syncytial virus
    • Langedijk JP, Schaaper WM, Meloen RH, Van Oirschot JT. Proposed three-dimensional model for the attachment protein G of respiratory syncytial virus. J. Gen. Virol. 1996; 77(Pt 6): 1249-1257.
    • (1996) J. Gen. Virol , vol.77 , Issue.PART 6 , pp. 1249-1257
    • Langedijk, J.P.1    Schaaper, W.M.2    Meloen, R.H.3    Van Oirschot, J.T.4
  • 34
    • 0034575693 scopus 로고    scopus 로고
    • Physico-chemical characterization and immunogenicity studies of peptide and polysaccharide conjugate vaccines based on a promising new carrier protein, the recombinant Klebsiella pneumoniae OmpA
    • Haeuw JF, Libon C, Zanna L, Goetsch L, Champion T, Nguyen TN, Bonnefoy JY, Corvaia N, Beck A. Physico-chemical characterization and immunogenicity studies of peptide and polysaccharide conjugate vaccines based on a promising new carrier protein, the recombinant Klebsiella pneumoniae OmpA. Dev. Biol. (Basel) 2000; 103: 245-250.
    • (2000) Dev. Biol. (Basel) , vol.103 , pp. 245-250
    • Haeuw, J.F.1    Libon, C.2    Zanna, L.3    Goetsch, L.4    Champion, T.5    Nguyen, T.N.6    Bonnefoy, J.Y.7    Corvaia, N.8    Beck, A.9
  • 36
    • 0037495845 scopus 로고    scopus 로고
    • Synthesis, refolding and protective immune responses of a potential antigen for human respiratory syncytial virus vaccine
    • Klinguer-Hamour C, Bussat MC, Plotnicky H, Velin D, Corvaia N, Nguyen T, Beck A. Synthesis, refolding and protective immune responses of a potential antigen for human respiratory syncytial virus vaccine. J. Pept. Res. 2003; 62(1): 27-36.
    • (2003) J. Pept. Res , vol.62 , Issue.1 , pp. 27-36
    • Klinguer-Hamour, C.1    Bussat, M.C.2    Plotnicky, H.3    Velin, D.4    Corvaia, N.5    Nguyen, T.6    Beck, A.7
  • 37
    • 34848908622 scopus 로고    scopus 로고
    • Structural study of chemically synthesized Tat proteins from a HIV-1 primary isolate: Evidence that Tat is a natively unfolded protein which adopts a "pre-molten globuble" state in solution
    • submitted
    • Foucault M, Guillon C, Mayol K, Menduni R, Bussat MC, Klinguer-Hamour C, Beck A, Verrier B, Haser R, Gouet P. Structural study of chemically synthesized Tat proteins from a HIV-1 primary isolate: evidence that Tat is a natively unfolded protein which adopts a "pre-molten globuble" state in solution. 2007; submitted.
    • (2007)
    • Foucault, M.1    Guillon, C.2    Mayol, K.3    Menduni, R.4    Bussat, M.C.5    Klinguer-Hamour, C.6    Beck, A.7    Verrier, B.8    Haser, R.9    Gouet, P.10
  • 38
    • 4644265609 scopus 로고    scopus 로고
    • Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen
    • Martin P, Parroche P, Chatel L, Barretto C, Beck A, Trepo C, Bain C, Lone YC, Inchauspe G, Fournillier A. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen. J. Med. Virol. 2004; 74(3): 397-405.
    • (2004) J. Med. Virol , vol.74 , Issue.3 , pp. 397-405
    • Martin, P.1    Parroche, P.2    Chatel, L.3    Barretto, C.4    Beck, A.5    Trepo, C.6    Bain, C.7    Lone, Y.C.8    Inchauspe, G.9    Fournillier, A.10
  • 46
    • 0034818555 scopus 로고    scopus 로고
    • Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae
    • Goetsch L, Gonzalez A, Plotnicky-Gilquin H, Haeuw JF, Aubry JP, Beck A, Bonnefoy JY, Corvaia N. Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae. Infect. Immun. 2001; 69(10): 6434-6444.
    • (2001) Infect. Immun , vol.69 , Issue.10 , pp. 6434-6444
    • Goetsch, L.1    Gonzalez, A.2    Plotnicky-Gilquin, H.3    Haeuw, J.F.4    Aubry, J.P.5    Beck, A.6    Bonnefoy, J.Y.7    Corvaia, N.8
  • 48
    • 0037157262 scopus 로고    scopus 로고
    • Streptococcus pneumoniae polysaccharides conjugated to the outer membrane protein A from Klebsiella pneumoniae elicit protective antibodies
    • Libon C, Haeuw JF, Crouzet F, Mugnier C, Bonnefoy JY, Beck A, Corvaia N. Streptococcus pneumoniae polysaccharides conjugated to the outer membrane protein A from Klebsiella pneumoniae elicit protective antibodies. Vaccine 2002; 20(17-18): 2174-2180.
    • (2002) Vaccine , vol.20 , Issue.17-18 , pp. 2174-2180
    • Libon, C.1    Haeuw, J.F.2    Crouzet, F.3    Mugnier, C.4    Bonnefoy, J.Y.5    Beck, A.6    Corvaia, N.7
  • 51
    • 0037903332 scopus 로고    scopus 로고
    • The immunodominant influenza matrix T cell epitope recognized in human induces influenza protection in HLA-A2/ K(b) transgenic mice
    • Plotnicky H, Cyblat-Chanal D, Aubry JP, Derouet F, Klinguer-Hamour C, Beck A, Bonnefoy JY, Corvaia N. The immunodominant influenza matrix T cell epitope recognized in human induces influenza protection in HLA-A2/ K(b) transgenic mice. Virology 2003; 309(2): 320-329.
    • (2003) Virology , vol.309 , Issue.2 , pp. 320-329
    • Plotnicky, H.1    Cyblat-Chanal, D.2    Aubry, J.P.3    Derouet, F.4    Klinguer-Hamour, C.5    Beck, A.6    Bonnefoy, J.Y.7    Corvaia, N.8
  • 53
    • 34848902269 scopus 로고    scopus 로고
    • Comparative study of the membrane association states of Outer membrane protein A of Klebsiella pneumoniae in new galenic formulations applied to active immunotherapy
    • in preparation
    • Sugawara M, Haeuw JF, Goetsch L, Klinguer-Hamour C, Corvaia N, Beck A, Milon A. Comparative study of the membrane association states of Outer membrane protein A of Klebsiella pneumoniae in new galenic formulations applied to active immunotherapy. 2007; in preparation.
    • (2007)
    • Sugawara, M.1    Haeuw, J.F.2    Goetsch, L.3    Klinguer-Hamour, C.4    Corvaia, N.5    Beck, A.6    Milon, A.7
  • 54
    • 8444252052 scopus 로고    scopus 로고
    • Final antigenic Melan-A peptides produced directly by the proteasomes are preferentially selected for presentation by HLA-A*0201 in melanoma cells
    • Chapatte L, Servis C, Valmori D, Burlet-Schiltz O, Dayer J, Monsarrat B, Romero P, Levy F. Final antigenic Melan-A peptides produced directly by the proteasomes are preferentially selected for presentation by HLA-A*0201 in melanoma cells. J. Immunol. 2004; 173(10): 6033-6040.
    • (2004) J. Immunol , vol.173 , Issue.10 , pp. 6033-6040
    • Chapatte, L.1    Servis, C.2    Valmori, D.3    Burlet-Schiltz, O.4    Dayer, J.5    Monsarrat, B.6    Romero, P.7    Levy, F.8
  • 55
    • 23944483437 scopus 로고    scopus 로고
    • Cell-penetrating peptides: Tools for intracellular delivery of therapeutics
    • Deshayes S, Morris MC, Divita G, Heitz F. Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell Mol. Life Sci. 2005; 62(16): 1839-1849.
    • (2005) Cell Mol. Life Sci , vol.62 , Issue.16 , pp. 1839-1849
    • Deshayes, S.1    Morris, M.C.2    Divita, G.3    Heitz, F.4
  • 56
    • 33645751057 scopus 로고    scopus 로고
    • Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide
    • Tan M, Lan KH, Yao J, Lu CH, Sun MH, Neal CL, Lu J, Yu DH. Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide. Cancer Res. 2006; 66(7): 3764-3772.
    • (2006) Cancer Res , vol.66 , Issue.7 , pp. 3764-3772
    • Tan, M.1    Lan, K.H.2    Yao, J.3    Lu, C.H.4    Sun, M.H.5    Neal, C.L.6    Lu, J.7    Yu, D.H.8
  • 59
    • 32344438402 scopus 로고    scopus 로고
    • The second wave in kinase cancer drugs
    • Garber K. The second wave in kinase cancer drugs. Nat. Biotechnol. 2006; 24(2): 127-130.
    • (2006) Nat. Biotechnol , vol.24 , Issue.2 , pp. 127-130
    • Garber, K.1
  • 61
    • 33646172632 scopus 로고    scopus 로고
    • The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms
    • Ferrara C, Stuart F, Sondermann P, Brunker P, Umana P. The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. J. Biol. Chem. 2006; 281(8): 5032-5036.
    • (2006) J. Biol. Chem , vol.281 , Issue.8 , pp. 5032-5036
    • Ferrara, C.1    Stuart, F.2    Sondermann, P.3    Brunker, P.4    Umana, P.5
  • 63
    • 23044493251 scopus 로고    scopus 로고
    • Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer
    • Hofmann F, Garcia-Echeverria C. Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer. Drug Discov. Today 2005; 10(15): 1041-1047.
    • (2005) Drug Discov. Today , vol.10 , Issue.15 , pp. 1041-1047
    • Hofmann, F.1    Garcia-Echeverria, C.2
  • 64
    • 10344247119 scopus 로고    scopus 로고
    • A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts
    • Goetsch L, Gonzalez A, Leger O, Beck A, Pauwels PJ, Haeuw JF, Corvaia N. A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts. Int. J. Cancer 2005; 113(2): 316-328.
    • (2005) Int. J. Cancer , vol.113 , Issue.2 , pp. 316-328
    • Goetsch, L.1    Gonzalez, A.2    Leger, O.3    Beck, A.4    Pauwels, P.J.5    Haeuw, J.F.6    Corvaia, N.7
  • 65
    • 33644555493 scopus 로고    scopus 로고
    • Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: Implications for anti-insulin-like growth factor therapy in breast cancer
    • Sachdev D, Singh R, Fujita-Yamaguchi Y, Yee D. Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer. Cancer Res. 2006; 66(4): 2391-2402.
    • (2006) Cancer Res , vol.66 , Issue.4 , pp. 2391-2402
    • Sachdev, D.1    Singh, R.2    Fujita-Yamaguchi, Y.3    Yee, D.4
  • 67
    • 33744995253 scopus 로고    scopus 로고
    • Optimization of a reversed-phase high-performance liquid chromatography/ mass spectrometry method for characterizing recombinant antibody heterogeneity and stability
    • Dillon TM, Bondarenko PV, Rehder DS, Pipes GD, Kleemann GR, Ricci MS. Optimization of a reversed-phase high-performance liquid chromatography/ mass spectrometry method for characterizing recombinant antibody heterogeneity and stability. J. Chromatogr. A 2006; 1120(1-2): 112-120.
    • (2006) J. Chromatogr. A , vol.1120 , Issue.1-2 , pp. 112-120
    • Dillon, T.M.1    Bondarenko, P.V.2    Rehder, D.S.3    Pipes, G.D.4    Kleemann, G.R.5    Ricci, M.S.6
  • 68
    • 29044447751 scopus 로고    scopus 로고
    • Reversed-phase liquid chromatography/mass spectrometry analysis of reduced monoclonal antibodies in pharmaceutics
    • Rehder DS, Dillon TM, Pipes GD, Bondarenko PV. Reversed-phase liquid chromatography/mass spectrometry analysis of reduced monoclonal antibodies in pharmaceutics. J. Chromatogr. A 2006; 1102(1-2): 164-175.
    • (2006) J. Chromatogr. A , vol.1102 , Issue.1-2 , pp. 164-175
    • Rehder, D.S.1    Dillon, T.M.2    Pipes, G.D.3    Bondarenko, P.V.4
  • 69
    • 33646398313 scopus 로고    scopus 로고
    • Improving mass accuracy of high performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry of intact antibodies
    • Gadgil HS, Pipes GD, Dillon TM, Treuheit MJ, Bondarenko PV. Improving mass accuracy of high performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry of intact antibodies. J. Am. Soc. Mass Spectrom. 2006; 17(6): 867-872.
    • (2006) J. Am. Soc. Mass Spectrom , vol.17 , Issue.6 , pp. 867-872
    • Gadgil, H.S.1    Pipes, G.D.2    Dillon, T.M.3    Treuheit, M.J.4    Bondarenko, P.V.5
  • 71
    • 13544276336 scopus 로고    scopus 로고
    • Glycosylation of recombinant antibody therapeutics
    • Jefferis R. Glycosylation of recombinant antibody therapeutics. Biotechnol. Prog. 2005; 21(1): 11-16.
    • (2005) Biotechnol. Prog , vol.21 , Issue.1 , pp. 11-16
    • Jefferis, R.1
  • 72
    • 31844447560 scopus 로고    scopus 로고
    • Impact of variable domain glycosylation on antibody clearance: An LC/MS characterization
    • Huang L, Biolsi S, Bales KR, Kuchibhotla U. Impact of variable domain glycosylation on antibody clearance: an LC/MS characterization. Anal. Biochem. 2006; 349(2): 197-207.
    • (2006) Anal. Biochem , vol.349 , Issue.2 , pp. 197-207
    • Huang, L.1    Biolsi, S.2    Bales, K.R.3    Kuchibhotla, U.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.